We are live on
!
Find out more
AC
Aristides Capital Portfolio holdings
AUM
$462M
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+1.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+109.78%
5 Year Est. Return
+150.66%
10 Year Est. Return
–
AUM
$230M
AUM Growth
-$15.8M
(-6.4%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
46.91%
Holding
221
New
33
Increased
17
Reduced
27
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.82M |
| 2 |
SP
SP Plus Corporation
SP
|
+$1.53M |
| 3 |
Turning Point Brands
TPB
|
+$801K |
| 4 |
Stratasys
SSYS
|
+$791K |
| 5 |
Atlanta Braves Holdings Series B
BATRK
|
+$620K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$8.1M |
| 2 |
Silicon Motion
SIMO
|
+$2.42M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$1.84M |
| 4 |
IonQ
IONQ
|
+$1.49M |
| 5 |
Evertec
EVTC
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.67% |
| 2 | Industrials | 7.44% |
| 3 | Consumer Discretionary | 7.13% |
| 4 | Financials | 6.59% |
| 5 | Communication Services | 5.27% |
Similar funds
PRCP
PC
GLAM
NG
SHWM
CPIM
HSA
CWWM
Aristides Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Aristides Capital held 221 positions worth $230M, down 6.4% from $246M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Aristides Capital withdrew a net $11.3M in Q3 2023, closing 39 positions and reducing 27 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $8.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Aristides Capital opened a new position in SP Plus Corporation worth $1.43M.
- Aristides Capital's largest Q3 2023 buy was SP Plus Corporation: 39,554 shares worth $1.43M.
- Aristides Capital added most to Activision Blizzard in Q3 2023, an estimated $1.82M increase.
- Aristides Capital's biggest Q3 2023 reduction was Evertec, cutting an estimated $1.32M.
- Aristides Capital fully exited iShares Biotechnology ETF in Q3 2023, selling an estimated $8.1M.
- Aristides Capital's ten largest holdings make up 47% of its $230M portfolio in Q3 2023.
- Aristides Capital opened 33 new positions and closed 39 in Q3 2023.
- Aristides Capital's portfolio value fell 6.4% quarter-over-quarter to $230M.
Based on Aristides Capital's 13F filing for Q3 2023, filed 14 Nov 2023.